A Novel TPM1 Mutation Causes Familial Hypertrophic Cardiomyopathy in an Indian Family: Genetic and Clinical...

Area of Science:

• Cardiovascular Genetics
• Molecular Cardiology

Background:

• Hypertrophic cardiomyopathy (HCM) is a prevalent inherited cardiac disorder affecting 1 in 250 individuals.
• HCM results from mutations in genes encoding sarcomeric proteins, crucial for heart muscle contraction.
• Mutations in the α-tropomyosin (TPM1) gene are implicated in various cardiomyopathies, including HCM.

Observation:

• A novel heterozygous TPM1 mutation (NM_001018005.2:c.203A>G, p.Gln68Arg) was identified.
• This mutation co-segregated within an Indian family diagnosed with hypertrophic cardiomyopathy.
• TPM1 mutations account for less than 1% of HCM cases, but can include high-risk variants.

Findings:

• The study identified a new TPM1 mutation linked to hypertrophic cardiomyopathy.
• The identified mutation (p.Gln68Arg) was observed to segregate with the HCM phenotype in the affected family.
• This expands the known spectrum of TPM1 mutations associated with HCM.

Implications:

• This finding broadens the understanding of the genetic basis of hypertrophic cardiomyopathy.
• It highlights the importance of TPM1 gene analysis in diagnosing HCM, particularly in familial cases.
• Further research into TPM1 mutations may reveal new therapeutic targets for HCM.